The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 9, 2001, Pages 4358-4363

  De Block, Christophe E M ^a   De Leeuw, Ivo H ^a   Decochez, Katelijn ^b   Winnock, Frederic ^b   Van Autreve, Jan ^b   Van Campenhout, Christel M ^a   Martin, Manou ^a   Gorus, Frans K ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b DIABETES RESEARCH CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE ANTIBODY; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ ANTIGEN; PARIETAL CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE ANTIBODY; THYROGASTRIC AUTOANTIBODY; THYROID PEROXIDASE; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIBODY DETECTION; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; PERNICIOUS ANEMIA; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RELATIVE; RISK FACTOR; STOMACH PARIETAL CELL; THYROID DISEASE;

EID: 0034851985     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.9.7833     Document Type: Article

References (55)

1. Type 1 diabetes mellitus: A chronic autoimmune disease
2. The pathogenesis of insulin-dependent diabetes mellitus
3. HLA DQβ-gene contributes to susceptibility and resistance to insulin-dependent diabetic individuals
4. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus
5. Complementation of HLA DQA and -DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus
6. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies
7. Identification of the 64 kD autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
8. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insuloma
9. IA-2 autoantibodies complement GAD-65 autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
10. First-degree relatives of patients with type 1 diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion
11. Associations of GAD65- and IA-2 autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings
12. Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers
13. High prevalence of manifestations of gastric autoimmunity in parietal cell-antibody positive type 1 (insulin-dependent) diabetic patients
14. In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302
15. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children
16. Prevalence of islet cell and thyrogastric autoantibodies in Sudanese patients with type 1 diabetes
17. Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus
18. Clinical and subclinical organ-specific autoimmune manifestations in Type 1 (insulin-dependent) diabetic patients and their first-degree relatives
19. GAD-65, but not IA-2 antibodies are associated with thyrogastric autoimmunity in type 1 diabetes
20. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in type 1 diabetes
21. Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin dependent diabetes
22. Soluble transferrin receptor level: A new marker of iron deficiency anaemia, a common manifestation of gastric autoimmunity in type 1 diabetes
23. Mechanisms of disease: Pernicious anemia
24. Chronic autoimmune thyroiditis
25. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham survey
26. Diabetes mellitus and thyroid disease
27. Auto-immunity in children with diabetes mellitus and in their relatives
28. Islet cell and other organ-specific autoantibodies in healthy first-degree relatives to insulin-dependent
29. Autoimmunity in juvenile diabetics and their families
30. Evidence that type I diabetes and thyrogastric autoimmunity have different genetic determinants
31. Insulin autoantibodies and high titer islet cell antibodies are preferentially associated with the HLA-DQA1*0301-DQB1*0302 haplotype at clinical onset of type 1 diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years
32. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial islet autoantibody workshop
33. Population screening for autoimmune thyroid disease
34. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: The importance of diabetes registries in disclosing interactions between HLA DQ- and insulin gene-linked risk
35. Immunological studies of aging
36. Evidence for a primary autoimmune type of diabetes mellitus
37. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease
38. Glutamic acid decarboxylase antibodies in relation to other antibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes
39. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: Relation to insulin-dependent diabetes mellitus
40. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus
41. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DQA1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus
42. The genetics of Graves' disease
43. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type 1 diabetic patients
44. Human histocompatibility leucocyte antigen DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population
45. The genetics of Hashimoto's disease
46. HLA associations with Hashimoto's thyroiditis
47. Genetics of autoimmune thyroid disease: Lack of evidence for linkage to HLA within families
48. Typing for major histocompatibility complex class II antigens in thyroid tissue blocks: Association of Hashimoto's thyroiditis with HLA-DQA1*0301 and DQB1*0201 alleles
49. Comparative genetics of type 1 diabetes and autoimmune disease. Common loci, common pathways?
50. Are thyrogastric autoantibodies associated with an increased susceptibility to developing type 1 (insulin-dependent) diabetes? A study in identical twins
51. Progression to type 1 diabetes in autoimmune endocrine patients with islet cell antibodies
52. Anti-pancreatic autoimmunity and Graves' disease: Study of a cohort of 600 Caucasian patients
53. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus
54. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism